Antidepressant use and orthostatic hypotension in older adults living with mild-to-moderate Alzheimer disease

dc.check.date2021-07-15
dc.check.infoAccess to this article is restricted until 12 months after publication by request of the publisher.en
dc.contributorMolloy, D. Williamen
dc.contributor.authorDyer, Adam H.
dc.contributor.authorMurphy, Claire
dc.contributor.authorBriggs, Robert
dc.contributor.authorLawlor, Brian
dc.contributor.authorKennelly, Sean P. for the NILVAD Study Group
dc.contributor.funderSeventh Framework Programmeen
dc.date.accessioned2020-09-11T10:46:10Z
dc.date.available2020-09-11T10:46:10Z
dc.date.issued2020-07-15
dc.date.updated2020-09-11T10:28:28Z
dc.description.abstractObjectives: Antidepressant use is often reported as a risk factor for Orthostatic Hypotension (OH), however this relationship has never been explored in those with mild/moderate Alzheimer Disease (AD), who may represent a particularly vulnerable cohort. Methods: We performed a cross‐sectional analysis of baseline data from the NILVAD study. Participants with mild‐moderate AD were recruited from 23 centres in nine countries. Systolic and Diastolic Blood Pressure (SBP/DBP) was recorded in the seated position and after both 1 and 5 minutes of standing. OH was defined as a drop of ≥20 mmHg SBP/≥10 mmHg DBP. We examined the relationship between antidepressant use, orthostatic BP drop and the presence of OH, controlling for important covariates. Results: Of 509 participants (72.9 ± 8.3 years, 61.9% female), two‐fifths (39.1%; 199/509) were prescribed a regular antidepressant. Antidepressant use was associated with a significantly greater SBP and DBP drop at 5 minutes (β: 1.83, 0.16‐3.50, P = .03 for SBP; β: 1.13, 0.02‐2.25, P < .05 for DBP). Selective Serotonin Reuptake Inhibitor (SSRI) use was associated with a significantly greater likelihood of OH (OR 2.0, 1.1‐3.6, P = .02). Both findings persisted following robust covariate adjustment. Conclusions: In older adults with AD, antidepressants were associated with a significantly greater SBP/DBP drop at 5 minutes. SSRI use in particular may be a risk factor for OH. This emphasises the need to screen older antidepressant users, and particularly those with AD, for ongoing orthostatic symptoms in order to reduce the risk of falls in this vulnerable cohort.en
dc.description.statusPeer revieweden
dc.description.versionAccepted Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationDyer, A. H., Murphy, C., Briggs, R., Lawlor, B. and Kennelly, S. P. for the NILVAD Study Group (2020) 'Antidepressant use and orthostatic hypotension in older adults living with mild-to-moderate Alzheimer disease', International Journal of Geriatric Psychiatry. doi: 10.1002/gps.5377en
dc.identifier.doi10.1002/gps.5377en
dc.identifier.eissn1099-1166
dc.identifier.issn0885-6230
dc.identifier.journaltitleInternational Journal of Geriatric Psychiatryen
dc.identifier.urihttps://hdl.handle.net/10468/10511
dc.language.isoenen
dc.publisherJohn Wiley & Sons, Inc.en
dc.relation.projectinfo:eu-repo/grantAgreement/EC/FP7::SP1::HEALTH/279093/EU/A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease/NILVADen
dc.rights© 2020, John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Dyer, A. H., Murphy, C., Briggs, R., Lawlor, B. and Kennelly, S. P. for the NILVAD Study Group (2020) 'Antidepressant use and orthostatic hypotension in older adults living with mild-to-moderate Alzheimer disease', International Journal of Geriatric Psychiatry, doi: 10.1002/gps.5377, which has been published in final form at https://doi.org/10.1002/gps.5377. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.en
dc.subjectAlzheimer's diseaseen
dc.subjectAntidepressanten
dc.subjectDementiaen
dc.subjectFallsen
dc.subjectOrthostatic hypotensionen
dc.subjectSelective-serotonin reuptake inhibitoren
dc.titleAntidepressant use and orthostatic hypotension in older adults living with mild-to-moderate Alzheimer diseaseen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
13457.pdf
Size:
324.06 KB
Format:
Adobe Portable Document Format
Description:
Accepted Version
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description: